Harpoon Therapeutics, Inc

About Harpoon Therapeutics, Inc

Harpoon Therapeutics is an immuno-oncology company using a proprietary technology platform focused on T cell engagement to discover and develop novel biologics for the treatment of cancer and other diseases. The company is developing a broad portfolio of drug candidates, and plans to develop its own oncology products in the U.S., as well as selectively partner other products to access global markets.

LEADERSHIP:

CEO: Gerald McMahon, Ph.D.